Intracellular metabolism of CycloSaligenyl 3'-azido-2',3'- dideoxythymidine monophosphate, a prodrug of 3'-azido-2',3'-dideoxythymidine (zidovudine)

Molecular Pharmacology

Volumn 56, Issue 6, 1999, Pages 1354-136

  Balzarini, Jan ^a   Naesens, Lieve ^a   Aquaro, S ^b   Knispel, T ^c   Perno, C F ^b,d   De Clercq, E ^a   Meier, C ^c  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF HAMBURG   (Germany)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PRODRUG; THYMIDINE KINASE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CONCENTRATION RESPONSE; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG METABOLISM; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; T LYMPHOCYTE; TIME;

ANTI-HIV AGENTS; CELL LINE; CULTURE MEDIA; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; PHOSPHORIC ACID ESTERS; PRODRUGS; STAVUDINE; THYMIDINE KINASE; THYMINE NUCLEOTIDES; TRITIUM; TUMOR CELLS, CULTURED; ZIDOVUDINE;

EID: 0032731244     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Balzarini J, Cooney DA, Dalal M, Kang G-J, Cupp JE, De Clercq E, Broder S and Johns DG (1987a) 2′,3′-Dideoxycytidine: Regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis. Mol Pharmacol 32:798-806.
2. Balzarini J, Hao Z, Herdewijn P, Johns DG and De Clercq E (1991) Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Proc Natl Acad Sci USA 88:1499-1503.
3. Balzarini J, Herdewijn P and De Clercq E (1989) Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) and 3′-azido-2′,3′-dideoxythymidine (AZT), two potent anti-HIV compounds. J Biol Chem 264: 6127-6133.
4. Balzarini J, Kang G-J, Dalal M, Herdewijn P, De Clercq E, Broder S and Johns DG (1987b) The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2′,3′-didehydro-2′,3′-dideoxyribonucleosides: A comparison with their parental 2′,3′-dideoxyribonucleosides. Mol Pharmacol 32:162-167.
5. Balzarini J, Karlsson A, Aquaro S, Perno C-F, Cahard D, Naesens L, De Clercq E and McGuigan C (1996) Mechanism of anti-HIV action of masked alaninyl d4TMP derivatives. Proc Natl Acad Sci USA 93:7295-7299.
6. Balzarini J, Karlsson A, Wang L, Bohman C, Horská K, Votruba I, Fridland A, Van Aerschot A, Herdewijn P and De Clercq E (1993) Eicar (5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide): A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis. J Biol Chem 268:24591-24599.
7. Farquhar D, Chen R and Khan S (1995) 5′-[4-(Pivaloyloxy)-1,3,2-dioxaphosphorinan-2-yl]-2′-deoxy-5- fluorouridine: A membrane-permeating prodrug of 5-fluoro-2′-deoxyuridylic acid (FdUMP). J Med Chem 38:488-495.
8. Farquhar D, Khan S, Srivastva DN and Saunders PP (1994) Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2′-deoxy-5-fluorouridine 5′-monophosphate (FdUMP): A strategy to introduce nucleotides into cells. J Med Chem 37:3902-3909.
9. Frick LW, Nelson DJ, St Clair MH, Furman PA and Krenitsky TA (1988) Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem Biophys Res Commun 154:124-129.
10. Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H and Barry DW (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83:8333-8337.
11. Girardet J-L, Perigaud C, Aubertin A-M, Gosselin G, Kirn A and Imbach J-L (1995) Increase of the anti-HIV activity of d4T in human T cell culture by the use of the SATE pronucleotide approach. Bioorg Med Chem Lett 5:2981-2984.
12. Johnson MA and Fridland A (1989) Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol Pharmacol 36:291-295.
13. McGuigan C, Cahard D, Salgado A, De Clercq E and Balzarini J (1996a) Phosphoramidates as potent prodrugs of anti-HIV nucleotides: Studies in the amino region. Antiviral Chem Chemother 7:31-36.
14. McGuigan C, Cahard D, Sheeka HM, De Clercq E and Balzarini J (1996b) Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. J Med Chem 39:1748-1753.
15. Meier C (1998) Pro-nucleotides: Recent advances in the design of efficient tools for the delivery of biologically active nucleoside monophosphates. Synlett 233:242.
16. Meier C, De Clercq E and Balzarini J (1998a) Nucleotide delivery from CycloSaligenyl-3′-azido-3′-deoxythymidine monophosphates (CycloSal-AZTMP). Eur J Org Chem 1998:837-846.
17. Meier C, Lorey M, De Clercq E and Balzarini J (1997a) Cyclic Saligenyl phosphotriesters of 2′,3′-dideoxy-2′,3′-didehydrothymidine (d4T): A new pronucleotide approach. Bioorg Med Chem Lett 7:99-104.
18. Meier C, Lorey M, De Clercq E and Balzarini J (1997b) CycloSaligenyl-3′-azido-2′,3′-dideoxythymidine monophosphate (CydoSal-AZTMP): A new pronucleotide approach? Nucleosides Nucleotides 16:793-796.
19. Meier C, Lorey M, De Clercq E and Balzarini J (1998b) CycloSal-2′,3′-dideoxy-2′,3′-didehydrothymidine monophosphate (CycloSal-d4TMP): Synthesis and antiviral evaluation of a new d4TMP delivery system. J Med Chem 41:1417-1427.
20. Perno CF, Balestra E, Aquaro S, Panti S, Cenci A, Lazzarino G, Tavazzi B, Di Pierro D, Balzarini J and Caliò R (1996) The potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines. Mol Pharmacol 50:359-366.
21. Perno CF, Yarchoan R, Cooney DA, Hartman NR, Gartner S, Popovic M, Hao Z, Gerrard TL, Wilson YA, Johns DG and Broder S (1988) Inhibition of human immunodeficiency virus (HIV-1/HTLV-III Ba-L) replication in fresh and cultured human peripheral blood monocyte/macrophages by AZT and related 2′,3′-dideoxynucleosides. J Exp Med 168:1111-1125.
22. Pompon A, Lefebvre I, Imbach J-L, Kahn S and Farquhar D (1994) Decomposition pathways of the mono- and bis(pivaloyloxymethyl) esters of azidothymidine 5′-monophosphate in cell extract and in tissue culture medium: An application of the "on line ISRP-cleaning" HPLC technique. Antiviral Chem Chemother 5:91-98.
23. Saboulard D, Naesens L, De Clercq E and Balzarini J (1999) Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine (d4T) and zidovudine (AZT). Mol Pharmacol, 56:693-704.
24. Starnes MC and Cheng Y-C (1987) Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J Biol Chem 262:988-991.
25. Törnevik Y, Jacobsson, Britton S and Eriksson S (1992) Intracellular metabolism of 3′-azidothymidine in isolated human peripheral blood mononuclear cells. J AIDS Res Human Retrovir 7:751-759.
26. Valette G, Pompon A, Girardet J-L, Cappellacci L, Franchetti P, Grifantini M, La Colla P, Loi AG, Perigaud C, Gosselin G and Imbach JL (1996) Decomposition pathways and in vitro HIV inhibitory effects of IsoddA pronucleotides: Toward a rational approach for intracellular delivery of nucleoside 5′-monophosphates. J Med Chem 39:1981-1990.
27. Witvrouw M, Balzarini J, Pannecouque C, Jhaumeer-Laulloo S, Esté JA, Schols D, Cherepanov P, Schmit J-C, Debyser Z, Vandamme A-M, Desmyter J, Ramadas SR and De Clercq E (1997) SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus. Antimicrob Agents Chemother 41:262-268.
28. Zimmerman TP, Mahony WB and Prus KL (1987) 3′-Azido-3′-deoxythymidine: An unusual nucleoside analog that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. J Biol Chem 262:5748-5754.